MedPath

Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin

Phase 3
Completed
Conditions
Hepatitis C
Hepatitis C, Chronic
Registration Number
NCT00040027
Lead Sponsor
SciClone Pharmaceuticals
Brief Summary

Chronic hepatitis C infection is one of the leading causes of chronic liver disease in the United States. Approximately one-third of patients with hepatitis C infection develop cirrhosis of the liver, which can lead to liver failure or liver cancer. The current treatment for hepatitis C infection in previously untreated patients is successful in only about half of patients. There is no established therapy for non-responders.

This is a randomized, double-blinded, multicenter trial to determine the effectiveness of thymosin alpha 1 (thymalfasin) 1.6 mg twice weekly plus PEGinterferon alfa-2a 180 ug/wk compared to placebo plus PEGinterferon alfa-2a in adults with chronic hepatitis C without cirrhosis who are non-responders to previous treatment with interferon or interferon plus ribavirin. The definition of non-response requires a positive HCV RNA test at the end of a course of at least 12 weeks of therapy. Patients will receive treatment for 12 months, and will be followed-up for a further 6 months after the end of therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (47)

University of Alabama - Knollwood Physician's Group Bldg.

🇺🇸

Mobile, Alabama, United States

Mayo Clinic

🇺🇸

Jacksonville, Florida, United States

Gastroenterology Associates of East Bay Medical Group

🇺🇸

Berkeley, California, United States

Scripps Clinic

🇺🇸

La Jolla, California, United States

Cedars-Sinai Medical Center

🇺🇸

Los Angeles, California, United States

California Pacific Medical Center

🇺🇸

San Francisco, California, United States

Veterans Administration Medical Center GI Section (111B)

🇺🇸

San Francisco, California, United States

Walter Reed Army Medical Center

🇺🇸

Washington, District of Columbia, United States

Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

University of Florida

🇺🇸

Gainesville, Florida, United States

Scroll for more (37 remaining)
University of Alabama - Knollwood Physician's Group Bldg.
🇺🇸Mobile, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.